    [Federal Register Volume 91, Number 58 (Thursday, March 26, 2026)]
    [Notices]
    [Pages 14721-14722]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 2026-05912]

    -----------------------------------------------------------------------

    DEPARTMENT OF JUSTICE

    Drug Enforcement Administration

    [Docket No. DEA-1666]

    Bulk Manufacturer of Controlled Substances Application: SpecGx
    LLC

    AGENCY: Drug Enforcement Administration, Justice.

    ACTION: Notice of application.

    -----------------------------------------------------------------------

    SUMMARY: SpecGx LLC has applied to be registered as a bulk manufacturer
    of basic class(es) of controlled substance(s). Refer to Supplementary
    Information listed below for further drug information.

    DATES: Registered bulk manufacturers of the affected basic class(es),
    and applicants, therefore, may submit electronic comments on or
    objections to the issuance of the proposed registration on or before
    May 26, 2026. Such persons may also file a written request for a
    hearing on the application on or before May 26, 2026.

    ADDRESSES: The Drug Enforcement Administration requires that all
    comments be submitted electronically through the Federal eRulemaking
    Portal, which provides the ability to type short comments directly into
    the comment field on the web page or attach a file for lengthier
    comments. Please go to https://www.regulations.gov and follow the
    online instructions at that site for submitting comments. Upon
    submission of your comment, you will receive a Comment Tracking Number.
    Please be

    [[Page 14722]]

    aware that submitted comments are not instantaneously available for
    public view on https://www.regulations.gov. If you have received a
    Comment Tracking Number, your comment has been successfully submitted
    and there is no need to resubmit the same comment.

    SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
    is notice that on February 4, 2026, SpecGx, LLC, 3600 North Second
    Street, Saint Louis, Missouri 63147-3457, applied to be registered as a
    bulk manufacturer of the following basic class(es) of controlled
    substance(s):

    ------------------------------------------------------------------------
             Controlled substance           Drug code         Schedule
    ------------------------------------------------------------------------
    Gamma Hydroxybutyric Acid............         2010  I
    Tetrahydrocannabinols................         7370  I
    Psilocybin...........................         7437  I
    Codeine-N-oxide......................         9053  I
    Dihydromorphine......................         9145  I
    Difenoxin............................         9168  I
    Morphine-N-oxide.....................         9307  I
    Normorphine..........................         9313  I
    Alphamethadol........................         9605  I
    Betamethadol.........................         9609  I
    Norlevorphanol.......................         9634  I
    Acetyl Fentanyl (N-(1-                        9821  I
     phenethylpiperidin-4-yl)-N-
     phenylacetamide).
    Butyryl Fentanyl.....................         9822  I
    Fentanyl related compounds as defined         9850  I
     in 21 CFR 1308.11(h).
    Amphetamine..........................         1100  II
    Methamphetamine......................         1105  II
    Lisdexamfetamine.....................         1205  II
    Methylphenidate......................         1724  II
    Nabilone.............................         7379  II
    ANPP (4-Anilino-N-phenethyl-4-                8333  II
     piperidine).
    Phenylacetone........................         8501  II
    Codeine..............................         9050  II
    Dihydrocodeine.......................         9120  II
    Oxycodone............................         9143  II
    Hydromorphone........................         9150  II
    Diphenoxylate........................         9170  II
    Ecgonine.............................         9180  II
    Hydrocodone..........................         9193  II
    Levorphanol..........................         9220  II
    Isomethadone.........................         9226  II
    Meperidine...........................         9230  II
    Meperidine intermediate-A............         9232  II
    Meperidine intermediate-B............         9233  II
    Meperidine intermediate-C............         9234  II
    Methadone............................         9250  II
    Methadone intermediate...............         9254  II
    Dextropropoxyphene, bulk (non-dosage          9273  II
     forms).
    Morphine.............................         9300  II
    Oripavine............................         9330  II
    Thebaine.............................         9333  II
    Opium tincture.......................         9630  II
    Opium, powdered......................         9639  II
    Oxymorphone..........................         9652  II
    Noroxymorphone.......................         9668  II
    Alfentanil...........................         9737  II
    Remifentanil.........................         9739  II
    Sufentanil...........................         9740  II
    Tapentadol...........................         9780  II
    Fentanyl.............................         9801  II
    ------------------------------------------------------------------------

        The company plans to bulk manufacture the listed controlled
    substances for sale to its customers and for internal use to produce
    non-controlled substances. In reference to drug code 7370
    (Tetrahydrocannabinols), the company plans to bulk manufacture this
    drug code as synthetic. No other activities for these drug codes are
    authorized for this registration.

    Thomas Prevoznik,
    Deputy Assistant Administrator.
    [FR Doc. 2026-05912 Filed 3-25-26; 8:45 am]
    BILLING CODE P